# Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen

> **NCT05512754** · PHASE4 · RECRUITING · sponsor: **University of Chicago** · enrollment: 200 (estimated)

## Conditions studied

- Elevated Serum PSA

## Interventions

- **DRUG:** Ibuprofen 400 mg

## Key facts

- **NCT ID:** NCT05512754
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05512754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05512754, "Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05512754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*